Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 7 | 3 | 2015 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2020 | 2020 | ||||||||
|
FTO alpha-ketoglutarate dependent dioxygenase | 0.486 | 0.885 | 8.4E-08 |
|
phenotype | 0.100 | None | 1.000 | 5 | 4 | 2012 | 2018 | ||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
phenotype | 0.100 | None | 1.000 | 4 | 2 | 2010 | 2019 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2012 | 2018 | ||||||||
|
aryl hydrocarbon receptor nuclear translocator like | 0.510 | 0.885 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2018 | ||||||||
|
haptoglobin | 0.412 | 0.885 | 1.7E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
neurofibromin 1 | 0.440 | 0.885 | 0.90 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
phenotype | 0.100 | None | 1.000 | 27 | 20 | 2008 | 2019 | ||||||||
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2013 | 2018 | ||||||||
|
phospholipase A2 group VI | 0.476 | 0.846 | 2.5E-10 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2018 | 2019 | ||||||||
|
glycogen synthase kinase 3 beta | 0.430 | 0.846 | 0.96 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2012 | 2017 | ||||||||
|
insulin receptor | 0.432 | 0.846 | 3.6E-05 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2019 | ||||||||
|
CD36 molecule | 0.446 | 0.846 | 1.1E-60 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2012 | 2019 | ||||||||
|
microsomal triglyceride transfer protein | 0.505 | 0.846 | 1.0E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
CD163 molecule | 0.427 | 0.846 | 8.3E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
phenotype | 0.100 | None | 1.000 | 13 | 8 | 2008 | 2019 | ||||||||
|
hepatocyte nuclear factor 4 alpha | 0.461 | 0.808 | 0.15 |
|
phenotype | 0.100 | None | 1.000 | 10 | 1 | 2009 | 2019 |